Understanding persistent bloodstream infections
Administrative Core
This study is looking at how our bodies and harmful germs interact when someone has a serious bloodstream infection that doesn't get better with regular treatments, and it's designed to help doctors find better ways to help patients recover.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center NIH-funded |
| Lab location | 1 site (Torrance, United States) |
| Project ID | NIH-11091663 on NIH RePORTER |
What this research studies
This research investigates the complex interactions between the host and pathogens that lead to severe bloodstream infections that do not respond to standard treatments. By employing a systems-biology approach, the project aims to integrate various expertise and technologies to enhance understanding and management of these infections. The Administrative Network Core will facilitate collaboration among researchers and ensure efficient coordination of resources and activities, ultimately aiming to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing life-threatening bloodstream infections that have not cleared with appropriate therapy.
Not a fit: Patients with bloodstream infections that respond well to standard treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment strategies for patients suffering from persistent bloodstream infections.
How similar studies have performed: Other research has shown promise in understanding host-pathogen interactions using systems-biology approaches, indicating potential for success in this area.
Where this research is happening
Torrance, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center — Torrance, United States (Active)
Researchers
- Principal investigator: Yeaman, Michael R — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Study coordinator: Yeaman, Michael R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.